Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPYY5 receptor antagonists

被引：19

作者：

Ogino, Yoshio ^{[1
]}

Ohtake, Norikazu ^{[1
]}

Nagae, Yoshikazu ^{[1
]}

Matsuda, Kenji ^{[1
]}

Ishikawa, Makoto ^{[1
]}

Moriya, Minoru ^{[1
]}

Kanesaka, Maki ^{[1
]}

Mitobe, Yuko ^{[1
]}

Ito, Junko ^{[1
]}

Kanno, Tetsuya ^{[1
]}

Ishihara, Akane ^{[1
]}

Iwaasa, Hisashi ^{[1
]}

Ohe, Tomoyuki ^{[1
]}

Kanatani, Akio ^{[1
]}

Fukami, Takehiro ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 18期

关键词：

neuropeptide Y; Y5; receptor; antagonist; anti-obesity; benzimidazole;

D O I：

10.1016/j.bmcl.2008.08.021

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Syntheses and structure-activity relationships of a novel class of 2-[3-oxospiro[isobenzofuran-1(3H), 1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists are described. Optimization of the lead compound 2a by incorporating substituents into the 5-position or into both the 5-and 6-positions of the benzimidazole core part led to the identification of 5-(5-methyl-1,2,4-oxadiazol-2-yl) benzimidazole (2r: IC(50) = 3.3 nM) and 5-(2-methyltetrazol-5-yl) benzimidazole (2u: IC(50) = 5.9 nM), both of which are potent, selective, and orally bioavailable Y5 receptor antagonists. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.

引用

页码：4997 / 5001

页数：5

共 50 条

[41] Synthesis and structure-activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility
Beliaev, Alexandre
Ferreira, Humberto S.
Learmonth, David A.
Bonifacio, Maria Joao
Torrao, Leonel
Pires, Nuno M.
Soares-da-Silva, Patricio
Kiss, Laszlo E.
PURE AND APPLIED CHEMISTRY, 2016, 88 (04) : 341 - 347
[42] Novel 5-hydroxytryptamine (5-HT3) receptor antagonists .1. Synthesis and structure-activity relationships of conformationally restricted fused imidazole derivatives
Ohta, M
Suzuki, T
Koide, T
Matsuhisa, A
Furuya, T
Miyata, K
Yanagisawa, I
CHEMICAL & PHARMACEUTICAL BULLETIN, 1996, 44 (05) : 991 - 999
[43] Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1H-pyrazol-3-yl)acetamides as Potent, Selective, and Orally Available Antagonists Targeting the Androgen Receptor
Chen, Changwei
Chai, Xin
Hu, Xueping
Lou, Shengying
Li, Dan
Hou, Tingjun
Cui, Sunliang
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (19) : 13074 - 13093
[44] Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists
Vu, CB
Pan, D
Peng, B
Kumaravel, G
Smits, G
Jin, XW
Phadke, D
Engber, T
Huang, C
Reilly, J
Tam, S
Grant, D
Hetu, G
Petter, RC
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2009 - 2018
[45] Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT6 receptor agonists
Mattsson, Cecilia
Svensson, Peder
Boettcher, Henning
Sonesson, Clas
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 : 578 - 588
[46] Structure-activity relationships of non-imidazole H3 receptor ligands.: Part 3:: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists
Gfesser, GA
Zhang, H
Dinges, J
Fox, GB
Pan, JB
Esbenshade, TA
Yao, BB
Witte, D
Miller, TR
Kang, CH
Krueger, KM
Bennani, YL
Hancock, AA
Faghih, R
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) : 673 - 676
[47] 4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists
Büttelmann, B
Alanine, A
Bourson, A
Gill, R
Heitz, MP
Mutel, V
Pinard, E
Trube, G
Wyler, R
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1759 - 1762
[48] Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-{2-[(3-substituted)-1-azetidinyl]ethyl}-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor
MacKenzie, AR
Marchington, AP
Middleton, DS
Newman, SD
Jones, BC
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (24) : 5365 - 5377
[49] Substituted 1, 3, 5-triazine derivatives as adenosine A2A receptor antagonists: Synthesis, structure-activity relationships and molecular modelling studies
Singh, Udaya
Bhat, Hans
MOVEMENT DISORDERS, 2014, 29 : S62 - S62
[50] Potent and selective PI3Kδ inhibitors: Structure-activity relationships of 8-alkoxy-2-(benzimidazol-1-yl)-6-morpholinopurines
Li, Jun
Safina, Brian
Sweeney, Zachary
Sutherlin, Daniel
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254

← 1 2 3 4 5 →